Skip to content

Ascorbic acid enhances antidepressant-like efficacy of esketamine: Hippocampal TARP-γ8-containing AMPA receptors mediate synaptic modulation.

Neurotherapeutics November 11, 2025 DOI: 10.1016/j.neurot.2025.e00786 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Preclinical animal study Peer reviewed
Population Rodents (preclinical animal model)
Interventions Esketamine Ascorbic acid
Topics Esketamine
Key points Ascorbic acid enhanced the antidepressant-like efficacy of esketamine in rodents, an effect the authors link to modulation of hippocampal synapses involving TARP-γ8-containing AMPA receptors. The authors propose that ascorbic acid may serve as an adjunct to strengthen esketamine's antidepressant-like actions via AMPA-receptor-mediated synaptic mechanisms.

Abstract

Ascorbic acid enhances antidepressant-like efficacy of esketamine: Hippocampal TARP-γ8-containing AMPA receptors mediate synaptic modulation.